Companies: 10,795·Total market cap: $144.5T

KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc.

KALVNASDAQHealthcare● Active

$26.95

+$0.00(+0.00%)

Market Cap$1.4B

P/E Ratio—

52W High$26.98

52W Low$9.83

Avg Volume3.4M

Open$26.96

Beta-0.11

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

KalVista Pharmaceuticals, Inc.（KALV）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · KALV · 截至 Jun 8, 2026

关键指标

EPS (TTM)—Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)—Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding—Shares outstanding history

Next EarningsTBAEarnings history

探索 KalVista Pharmaceuticals, Inc. 数据

分析师预测—

股息不分红

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

KalVista Pharmaceuticals, Inc.

$26.95+0.00%$1.4B #2

ADC Therapeutics S.A.

$1.03-21.97%$131.0M #3

Bicycle Therapeutics plc

$4.20-1.64%$291.5M #4

4D Molecular Therapeutics, Inc.

$8.64-13.69%$451.7M #5

Gossamer Bio, Inc.

$0.18-1.57%$41.1M #6

Olema Pharmaceuticals, Inc.

$10.31-3.46%$900.6M

关于 KalVista Pharmaceuticals, Inc.

CEOBenjamin L. Palleiko

IPO DateApr 9, 2015

Employees150

CountryUS

Websitekalvista.com

KalVista Pharmaceuticals, Inc. a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

KalVista Pharmaceuticals, Inc.（KALV）是 Biotechnology 行业的 Healthcare 类公司，于 Apr 9, 2015 在 NASDAQ 上市。截至最近交易日，KALV 股价为 $26.95，市值约为 $1.4B。过去12个月累计回报 —，年初至今回报 —。

常见问题

截至最近一个交易日，KalVista Pharmaceuticals, Inc.（KALV）股价为 $26.95，在 NASDAQ 上市，52周区间为 $9.83 – $26.98。

KALV 最新股价KALV quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议